• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Scoping Review Maps Polio Vaccine Barriers in Crises

by
November 8, 2026
in Health
Reading Time: 3 mins read
0
Scoping Review Maps Polio Vaccine Barriers in Crises

Scoping Review Maps Polio Vaccine Barriers in Crises

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new scoping review published in Conflict and Health has mapped the specific implementation barriers and coverage outcomes for the two primary polio vaccines used in humanitarian emergencies. The study, conducted by researchers including Jai Singh, Adam C. Levine, and Malabika Sarker, aims to inform vaccine selection strategies in disaster settings where global eradication efforts face significant logistical and sociopolitical hurdles. As the Global Polio Eradication Initiative targets the complete elimination of polio by 2029, understanding the distinct delivery requirements of Inactivated Polio Vaccine (IPV) and Oral Polio Vaccine (OPV) is critical for operational planning in unstable regions.

The research team followed the PRISMA extension for Scoping Reviews (PRISMA-ScR) to conduct a comprehensive search of major databases, including PubMed, EMBASE, Web of Science, and the Cochrane Library. The inclusion criteria required studies to focus on OPV and/or IPV campaigns in humanitarian crises, provide data on coverage or logistics, and be published in English within the last 20 years.

From an initial pool of 1,604 identified studies, only 24 met the strict inclusion criteria for the final analysis. The review found that IPV faces distinct operational challenges, primarily driven by higher operational costs and the requirement for skilled health workers.

In contrast, the barriers associated with OPV are largely sociopolitical and security-related. Prominent obstacles included bans on vaccination campaigns by armed groups and widespread misinformation that leads to community vaccine refusal. Despite these challenges, the review noted that OPV campaigns frequently achieved high coverage rates, with fourteen studies reporting that coverage often exceeded 90%, particularly when supported by effective partnerships and robust social mobilization efforts.

The review also examined coverage outcomes for IPV, finding that three studies reported high coverage rates ranging from 80% to 102.9%. These successful IPV campaigns were characterized by their delivery alongside OPV and strong community engagement. However, the evidence base for IPV is significantly smaller than that for OPV, with only three studies providing effectiveness data compared to fourteen for OPV.

The authors conclude that OPV emerges as the more practical mainstay for large-scale campaigns in crisis settings due to its lower cost and ease of administration. Nevertheless, they emphasize three critical caveats to this conclusion. First, the evidence base is asymmetric, with far fewer studies on IPV. Second, the outcome measured was administrative coverage rather than seroconversion or the actual interruption of transmission. Third, several OPV campaigns that reported high coverage were themselves responses to circulating vaccine-derived poliovirus, which complicates the interpretation of their success in general eradication efforts.

Despite the logistical, operational, and cost barriers limiting its scalability in emergencies, IPV remains essential to the final stages of polio eradication. The review underscores that regardless of the delivery method, effective partnerships and community engagement are critical to campaign success. The authors identify a significant knowledge gap regarding IPV-only immunization campaigns in crisis settings, indicating a need for further research to guide future implementation strategies in disaster areas.

This scoping review provides policymakers and operational actors with an evidence base to inform decisions on future implementation strategies in humanitarian contexts. By distinguishing between the logistical hurdles of IPV and the security challenges of OPV, the study offers a nuanced view of vaccine delivery in complex emergencies.

Subject of Research: Implementation barriers and coverage outcomes of polio vaccines in humanitarian settings

Article Title: Barriers & coverage outcomes of inactivated polio vaccine & oral polio vaccine in humanitarian settings: a scoping review

Article References: Singh, J., Levine, A. C., & Sarker, M. (2026). Barriers & coverage outcomes of inactivated polio vaccine & oral polio vaccine in humanitarian settings: a scoping review. Conflict and Health. https://doi.org/10.1186/s13031-026-00833-x

Image Credits: AI Generated

DOI: 10.1186/s13031-026-00833-x

Keywords: polio eradication, humanitarian settings, IPV, OPV, scoping review, vaccine coverage, Conflict and Health, implementation barriers, global health, emergency response, Barriers, coverage

News Source: Kristina Jarvis. (November 8, 2026). Scoping Review Maps Polio Vaccine Barriers in Crises. Scienmag.

Tags: Barriersconflict and healthcoverageemergency responseGlobal healthhumanitarian settingsimplementation barriersIPVOPVpolio eradicationscoping reviewvaccine coverage
Share12Tweet7Share2ShareShareShare1

Related Posts

Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

November 17, 2026
Syndesmotic Fixation Speeds Early Ankle Recovery but Matches Non-Fixation at Two Years

Syndesmotic Fixation Speeds Early Ankle Recovery but Matches Non-Fixation at Two Years

November 17, 2026

German Nationwide Survey Identifies Workplace Bullying Patterns Across Industries and Age Groups

November 17, 2026

Industrial Co-Exposure to Aluminum and Hydrocarbons Linked to Worker Anxiety

November 17, 2026

POPULAR NEWS

  • Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

    Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

    29 shares
    Share 12 Tweet 7
  • Syndesmotic Fixation Speeds Early Ankle Recovery but Matches Non-Fixation at Two Years

    29 shares
    Share 12 Tweet 7
  • German Nationwide Survey Identifies Workplace Bullying Patterns Across Industries and Age Groups

    29 shares
    Share 12 Tweet 7
  • TCAD Simulations Identify Efficiency Gains for Sustainable CZTS Solar Cells

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

Syndesmotic Fixation Speeds Early Ankle Recovery but Matches Non-Fixation at Two Years

German Nationwide Survey Identifies Workplace Bullying Patterns Across Industries and Age Groups

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.